期刊文献+

阿尔茨海默病与氧化应激 被引量:15

下载PDF
导出
摘要 关于阿尔兹海默病(AD)的病因和病理生理机制有多种假说,其中氧化应激假说认为AD的标志性病变β-淀粉样蛋白(Aβ)和磷酸化Tau等,能刺激活性氧簇(ROS)的生成,引起氧化应激,损伤神经元,引起认知功能障碍。氧化应激状态的持续激活进一步促进Aβ和磷酸化Tau的聚集和沉积、线粒体损伤,导致AD的发生并加速其病理进程。
出处 《国际神经病学神经外科学杂志》 北大核心 2015年第3期290-293,共4页 Journal of International Neurology and Neurosurgery
  • 相关文献

参考文献28

  • 1Querfurth HW, LaFerla FM. Alzheimer's disease. N EnglJ Med, 2010, 362(4): 329-344.
  • 2Moreira PI, Nunomura A, Nakamura M, et al. Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med, 2008, 44(8): 1493-1505.
  • 3Schrag M, Mueller C, Zabel M, et al. Oxidative stress in blood in Alzheimer' s disease and mild cognitive impairment ? a meta-analysis. Neurobiol Dis, 2013, 59: 100-110.
  • 4Lee C, Park GH, Lee SR, et al. Attenuation of - amyloid - induced oxidative cell death by sulforaphane via activation of NF - E 2 - related factor 2. Oxid Med Cell Longev, 20 1 3 , 2013: 313510.
  • 5Hou L, Lee H, Han F, et al. Modification of Amyloid -J3 1 -42 Fibril Structure by Methionine -3 5 Oxidation.J Alzhei?mers Dis, 2013, 37 ( 1 ) : 9 -18.
  • 6Tu S, Okamoto S, Lipton SA, et al. Oligomeric AI3 - in?duced synaptic dysfunction in Alzheimer's disease. Mol Neu?rodegener, 2014, 9 ( 1 ) : 48.
  • 7Porcellotti S, Fanelli F, Fracassi A, et al. Oxidative Stress during the Progression of 13 - Amyloid Pathology in the Neocor?tex of the Tg2576 Mouse Model of Alzheimer's Disease. Oxid Med Cell Longev, 2015, 2015: 967203.
  • 8Sachdeva AK, Chopra K. Lycopene abrogates AI3 ( 1 - 42 ) - mediated neuroinflammatory cascade in an experimental model of Alzheimer's disease.J Nutr Biochem, 2015,26 (7): 736-744.
  • 9Giordano CR, Terlecky IJ, Bollig - Fischer A, et al. Amy?loid - beta neuroprotection mediated by a targeted antioxidant. Sci Rep, 2014, 4: 4983.
  • 10Mukrasch MD, BiernatJ , von Bergen M, et al. Sites of tau important for aggregation populate I beta I - structure and bind to microtubules and polyanions.J Bioi Chern, 2005, 280 (26): 24978-24986.

二级参考文献52

  • 1Schapira AH. Targeting Mitoc'hondria for Neuroprotection inParkinson ' s Disease, Antioxid Redox Signal, 2012, 16 (9) : 965 -973.
  • 2Chu CT. Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol, 2006, 65 (5) : 423-432.
  • 3Webb JL, Ravikumar B, Atkins J, et al. Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem, 2003, 278(27) : 25009-25013.
  • 4Geisler S, Holmstrom KM, Treis A, et al. The PINK 1 / Par- kin-mediated mitophagy is compromised by PD-associated mu- tations. Autophagy, 2010, 6(7) : 871-878.
  • 5Lynch-Day MA, Mao K, Wang K, et al. The role of auto- phagy in Parkinson' s disease. Cold Spring Harb Perspect Med, 2012, 2(4) : 258-262.
  • 6Kondo Y, Kondo S. Autophagy and cancer therapy. Autopa- hagy, 2006 , 2 (2) : 85 -90.
  • 7Liang XH, Jackson S, Seaman M, et al. Induction of autoph- agy and inhibition of tumorigenesis by beclinl. Nature, 1999, 402(6762) : 672-676.
  • 8Shintani T, Klionsky DJ. Autophagy in health and disease : a double-edged sword. Science, 2004, 306 (5698) : 990-995.
  • 9Klionsky D J, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science, 2000 , 290 ( 5497 ) : 1717- 1721.
  • 10Cuervo AM, Dice JF. A receptor for the selective uptake and degradation of proteins by lysosomes. Science, 1996, 273 (5274) : 501-503.

共引文献10

同被引文献144

引证文献15

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部